期刊名称：CURRENT PHARMACEUTICAL ANALYSIS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Aims & Scope
Current Pharmaceutical Analysis publishes authoritative reviews, written by experts in the field on all the most recent advances in pharmaceutical and biomedical analysis. All aspects of the field are represented including drug analysis, analytical methodology and instrumentation. The journal is essential to all involved in pharmaceutical, biochemical and clinical analysis.
Indexed in
Chemical Abstracts, EMBASE, Scopus, Journal Citation Reports/Science Edition, Science Citation Index-Expanded, Index to Scientific Reviews, Biochemistry & Biophysics Citation Index
Instructions to Authors
Instructions for Authors
Online Manuscript Submission: Manuscripts must only be submitted online to the Bentham Science Editorial Office. It is preferable that authors first send an abstract to the editor, prior to submitting the full manuscript. The submitted abstract should outline the intended contents and coverage of the article. Abstracts may be sent either by e-mail to the editorial office at cpa@bentham.org or alternatively by the Internet at www.bentham.org/onlAbsSub.htm
After approval of your abstract by the editor, you may submit your full manuscript either by e-mail (file size restricted) or by online submission.
For short review manuscripts these may be submitted as an e-mail attachment (maximum file size 512 KB) to the editorial office at cpa@bentham.org
For online submission of manuscripts, these should be submitted via our online manuscript submission service available at www.bentham-mps.org or by FTP submission at www.bentham-ftp.org
For all online submissions, please provide your complete manuscript in the form of a single zipped folder containing soft copies of all the material (main text in MS word format, figures / illustrations, scanned photographs, tables, chemical structures drawn in ChemDraw) as separate files, while a PDF version of the entire manuscript must also be included with all the figures / illustrations / tables / chemical structures etc. embedded in the text exactly in the manner as they should appear in print.
Authors are required to proofread the PDF version of their manuscript before submission. The Publishers will not be responsible for any error occurring in the manuscript in this regard.
Manuscript Length: There is no limit on the number of pages that may be submitted, however, page lengths can vary for mini-reviews of up to 12 journal pages and for longer reviews up to 30 journal pages. A printed journal page is ca. 900 words (excluding diagrams and figures).
Manuscript Organization: The manuscript should be divided as: Title page, abstract and the main text. The text may be subdivided further according to the areas to be discussed. The Acknowledgements (if any) and Reference sections must then follow.
Conflict of Interest: Financial contributions to the work being reported should be clearly acknowledged, as should any potential conflict of interest.
Title Page: The first page should contain the title, the author's full names, institutional affiliations and location, with an asterisk in front of the name of the principal author. The corresponding author should be designated and their full address, business telephone and fax numbers and e-mail address must be stated to receive correspondence and galley proofs.
Abstract: The abstract should not exceed 200 words and should condense the essential features of the review article.
Key Words: Authors must supply up to six key words along with their manuscript.
Text: The main text should begin on a separate page and it may be subdivided into separate sections. The reference numbers should be given in square brackets in the text. Acknowledgements should be kept to a minimum.
Tables:
- Data Tables should be submitted in Microsoft Excel or in Microsoft Word table format.
- Each table should include a title/caption explaining what the table shows. Detailed legends may then follow.
- Tables should be given on separate pages with indications on the left hand margin to the text, as to the appropriate placement of the tables.
- Tables should not contain vertical rules.
- Columns and rows of data should be made visibly distinct by ensuring the borders of each cell display as black lines.
- Tables should be numbered consecutively in order of their citation in the body of the text, with Arabic numerals.
- If a reference is cited in both the table and text, insert a lettered footnote in the table to refer to the numbered reference in the text.
- Tabular data provided as additional files can be submitted as an Excel spreadsheet.
Figures / Illustrations:
All authors must strictly follow the guidelines below for preparing illustrations for publication in Current Pharmaceutical Analysis.
Editorial Requirements:
The quality of the illustrations printed in the journal largely depends on the quality of the figures/illustration provided by the author. In preparing artwork or graphics for publication, keep in mind the following points.
- Submit the original artwork or a photographic print of the original for publication.
- Do not submit photocopies. (Hardcopy submission requirement).
- Illustrations should be provided as separate files, not embedded in the text. (Hardcopy submission requirement).
- Remove all color from graphics except for those illustrations (Greyscale), which are intended to be printed in color.
- Good quality of hardcopy originals are a requirement.
- Figures should be referred to in the text with figure numbers in bold within round bracket.
- Revised manuscripts should contain a complete set of artwork and photographs.
Technical Details:
- Figures should be provided on high quality, white, smooth opaque paper. (Hardcopy requirement).
Format & Resolution:
- The following file formats can be accepted. (Preference in order of appearance): PDF, TIFF, JPEG, GIF.
- Illustrations must fit a single or double column format on the journal page, according to the following guideline below:
|
HEIGHT |
WIDTH |
|
SINGLE COLUMN |
24 cm (max) |
8.5 cm (max) |
|
DOUBLE COLUMN |
24 cm (max) |
18 cm (max) |
- Whenever possible, submit graphics that do not have to be reduced to fit the standard figure size.
- Use the best resolution available (hardcopy submission requirement). For online submission the maximum resolution is 300 dpi.
- Avoid textures and shadings giving a three-dimensional effect to the illustration.
- Symbols and lettering in the illustration should be of similar size.
- Smaller lettering is used.
- Font: Times New Roman or Helvetica is preferable. Font size: 10pt (maximum).
- Line drawings should have clear and sharp lines and should be of uniform density. Moreover, lines should be continuous without any breaks.
- Do not use lines thinner than 1 point.
Color Figures / Illustrations:
Photographs:
Submit high-contrast prints that are of single- or double-column width so that they will not have to be reduced when printed. Negatives are not acceptable. However, in case of hardcopy submission, color illustrations and plates can be published from 35 mm color slides.
Chemical Structures: Chemical structures must be prepared according to the guidelines below.
Structures should be prepared using a suitable drawing program e.g. ChemDraw and provided as separate file, submitted both on disk and in printed formats.
Numbers in bold should identify all chemical structure. If a name is also used to describe the compound, the associated number in bold should be in parenthesis,
Structure Drawing Preferences:
[As according to the ACS style sheet]
Drawing Settings:
Chain angle 120¡ã
Bond spacing 18% of width
Fixed length 14.4 pt (0.500cm, 0.2in)
Bold width 2.0 pt (0.071cm, 0.0278in)
Line width 0.6 pt (0.021cm, 0.0084in)
Margin width 1.6 pt (0.096cm)
Harsh spacing 2.5 pt (0.088cm, 0.0347in)
Text settings:
Font Times New Roman / Helvetica
Size 10pt
Under the Preference Choose:
Units points
Tolerances 3 pixels
Under Page Setup Use:
Paper US letter
Scale 100%
References: For the format of references, see the ACS Style Guide, pp 106-114,
Examples:
Journal Reference:
Barton, D.H.R.; Brewster, A.G.; Ley, S.V.; Rosenfield, M.N. J. Chem. Soc. Chem. Commun., 1977, 147, 2356.
Book Reference:
Rahman, A.-U.; Shah, Z. Stereoselective Synthesis in Organic Chemistry, Springer-Verlag: New York, 1993.
Copyright: It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication
Editorial Board
Editor-in-Chief:
Atta-ur-Rahman, FRS
HEJ Research Institute of Chemistry
University of Karachi
Karachi-75270
Pakistan
Editorial Advisory Board:
H.Y. Aboul-Enein (The National Research Center, Cairo, Egypt)
J. Angerer (University of Erlangen, Erlangen, Germany)
M. Aravagiri (Univ. of California at Los Angeles, Los Angeles, CA, USA)
D.W. Armstrong (Iowa State University, Ames, IA, USA)
Y. Baba (Nagoya University, Nagoya, Japan)
A. Berthod (University Claude-Bernard, Lyon, France)
A. Bolton (Novartis Pharma AG, Basel, Switzerland)
P. Bonato (Universidade de Sao Paulo, Sao Paulo, Brazil)
P. Boner (Ohio Northern University, Ada, OH, USA)
B. Buszewski (Nicholas Copernicus University, Torun, Poland)
M. Carini (University of Milan, Milan, Italy)
N. Celli (Consorzio Mario Negri Sud, Chieti, Italy)
B. Chankvetadze (University of Munster, Munster, Germany)
J. Crommen (University of Liege, Liege, Belgium)
N.D. Danielson (Miami University, Oxford, OH, USA)
A.K. Dash (Creighton University, Omaha, NE, USA)
J.G. Dorsey (Florida State University, Tallahassee, FL, USA)
M. Grote (University of Paderborn, Paderborn, Germany)
A. Guttman (Leopold-Franzens University Innsbruck, Innsbruck, Austria)
J. Haginaka (Mukogawa Womens University, Hyogo, Japan)
K. Hayakawa (Kanazawa University, Kanazawa, Japan)
G. Hopfgartner (University of Geneva, Geneva, Switzerland)
W.J. Hurst (Hershey Foods Corp., Hershey, PA, USA)
H.J. Issaq (SAIC Frederick Inc., NCI Frederick, Frederick, MD, USA)
J. Janca (University of La Rochelle, La Rochelle, France)
M. Jimidar (Johnson & Johnson Pharm. Res. and Develop., Beerse, Belgium)
K. Jinno (Toyohashi University of Technology, Toyohashi, Japan)
R. Kaliszan (Medical University of Gdansk, Gdansk, Poland)
R. Kanda (WRC-NSF Ltd., Bucks., UK)
N.K. Karamanos (University of Patras, Patras, Greece)
P.T. Kissinger (Bioanalytical Systems, Inc., West Lafayette, IN, USA)
A. Li (Covance Laboratories, Inc., Madison, WI, USA)
C.E. Lin (National Taiwan University, Taipei, Taiwan)
J.T. Lin (Western Reg. Res. Centre, ARS, USDA, Albany, CA, USA)
Y. Lin (Pacific Northwest National Laboratory, Richland, WA, USA)
H. Lingeman (Free University, Amsterdam, The Netherlands)
M. Lohitnavy (Naresuan University, Phitsanulok, Thailand)
G. Marko-Varga (AstraZeneca R&D Respiratory and Inflam., Lund, Sweden)
B.K. Matuszewski (Merck Research Laboratories, West Point, PA, USA)
H.H. Maurer (University of Saarland, Homburg, Germany)
W. Naidong (Bristol-Myers Squibb, New Brunswick, NJ, USA)
K. Nakashima (Nagasaki University, Nagasaki, Japan)
J.K. Nicholson (University of London, London, UK)
R.N. Ondarza (National Autonomus University of Mexico, Morelos, Mexico)
I.N. Papadoyannis (Aristotle University of Thessaloniki, Thessaloniki, Greece)
T.M. Phillips (NIH, Bethesda, MD, USA)
Z.E. Rassi (Oklahoma State University, Stillwater, OK, USA)
I. Salem (International Pharmaceutical Research Center, Amman, Jordan)
T. Santa (University of Tokyo, Tokyo, Japan)
J. Sherma (Lafayette College, Easton, PA, USA)
Z.K. Shihabi (Wake Forest University, Winston Salem, NC, USA)
N.R. Srinivas (Dr. Reddy's Laboratories Ltd., Hyderabad, India)
L.T. Taylor (Virginia Polytech. Inst. & State University, Blacksburg, VA, USA)
S. Terabe (University of Hyogo, Hyogo, Japan)
T. Toyooka (University of Shizuoka, Shizuoka, Japan)
D. Tsikas (Hannover Med. Sch. Inst. Clin. Pharmacology, Hannover, Germany)
J.-L. Veuthey (Geneva University, Geneva, Switzerland)
I.W. Wainer (National Institute on Aging, Baltimore, MD, USA)
R. Weinberger (CE Technologies, Chappaqua, NY, USA)
X. Xu (Louisiana State University Health Sciences Center, New Orleans, LA, USA)
M. Yamaguchi (Fukuoka University, Fukuoka, Japan)
Z. Yan (Johnson & Johnson Pharm. Res. & Develop., Spring House, PA, USA)
N. Yasui-Furukori (Hirosaki University, Hirosaki, Japan)
|
